manufacture refraction instruments, ophthalmic diagnostic instruments, visual acuity chart, ophthalmic unit, electric table
Currency:
USD
USD EUR GBP JPY AED AUD BRL CAD CHF DKK HKD IDR INR KRW MOP MYR NOK NZD PHP RUB SAR SEK THB TRY TWD SGD ZAR
Sign In or Join Free
USD
USD
EUR
GBP
JPY
AED
AUD
BRL
CAD
CHF
DKK
HKD
IDR
INR
KRW
MOP
MYR
NOK
NZD
PHP
RUB
SAR
SEK
THB
TRY
TWD
SGD
ZAR
Search History
Home / Blogs /
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
Home Blogs
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline

Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline

November 02, 2019

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its technology partner, Mannin, has received a $7.5M grant from the German state of Saxony. Mannin is a research-stage biotechnology company focused on the discovery, development, and commercialization of therapeutics for vascular diseases. It was founded in July 2012 and is led by President and CEO, Dr. George Nikopoulos. Q BioMed and Mannin have been partners since 2015.